Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Piccaro

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Mediterranean Journal of Hematology and Infectious Diseases|December 24, 2013
Targeting dormant bacilli to fight tuberculosisLanfranco Fattorini, Giovanni Piccaro, Alessandro Mustazzolu, et al.
The Journal of Antibiotics|May 7, 2015
Activity of lipophilic and hydrophilic drugs against dormant and replicating Mycobacterium tuberculosisGiovanni Piccaro, Giovanna Poce, Mariangela Biava, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2016
Mycobacterium tuberculosis Is Selectively Killed by Rifampin and Rifapentine in Hypoxia at Neutral pHAngelo Iacobino, Giovanni Piccaro, Federico Giannoni, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2013
Activities of drug combinations against Mycobacterium tuberculosis grown in aerobic and hypoxic acidic conditionsGiovanni Piccaro, Federico Giannoni, Perla Filippini, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2019
The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pHAngelo Iacobino, Federico Giannoni, Manuela Pardini, et al.
Antimicrobial Agents and Chemotherapy|October 8, 2014
Rifampin induces hydroxyl radical formation in Mycobacterium tuberculosisGiovanni Piccaro, Donatella Pietraforte, Federico Giannoni, et al.
Microorganisms|January 30, 2021
Moxifloxacin Activates the SOS Response in <i>Mycobacterium tuberculosis</i> in a Dose- and Time-Dependent MannerAngelo Iacobino, Giovanni Piccaro, Manuela Pardini, et al.
International Journal of Mycobacteriology|August 5, 2017
Fighting tuberculosis by drugs targeting nonreplicating <i>Mycobacterium tuberculosis</i> bacilliAngelo Iacobino, Giovanni Piccaro, Federico Giannoni, et al.
Antimicrobial Agents and Chemotherapy|March 31, 2010
Activity of drug combinations against dormant Mycobacterium tuberculosisPerla Filippini, Elisabetta Iona, Giovanni Piccaro, et al.
Annali Dell'Istituto Superiore Di Sanita|December 19, 2019
Use of probiotics in medical devices applied to some common pathologiesMaria Verrucci, Angelo Iacobino, Lanfranco Fattorini, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Mediterranean Journal of Hematology and Infectious Diseases|December 24, 2013
Targeting dormant bacilli to fight tuberculosisLanfranco Fattorini, Giovanni Piccaro, Alessandro Mustazzolu, et al.
The Journal of Antibiotics|May 7, 2015
Activity of lipophilic and hydrophilic drugs against dormant and replicating Mycobacterium tuberculosisGiovanni Piccaro, Giovanna Poce, Mariangela Biava, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2016
Mycobacterium tuberculosis Is Selectively Killed by Rifampin and Rifapentine in Hypoxia at Neutral pHAngelo Iacobino, Giovanni Piccaro, Federico Giannoni, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2013
Activities of drug combinations against Mycobacterium tuberculosis grown in aerobic and hypoxic acidic conditionsGiovanni Piccaro, Federico Giannoni, Perla Filippini, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2019
The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pHAngelo Iacobino, Federico Giannoni, Manuela Pardini, et al.
Antimicrobial Agents and Chemotherapy|October 8, 2014
Rifampin induces hydroxyl radical formation in Mycobacterium tuberculosisGiovanni Piccaro, Donatella Pietraforte, Federico Giannoni, et al.
Microorganisms|January 30, 2021
Moxifloxacin Activates the SOS Response in <i>Mycobacterium tuberculosis</i> in a Dose- and Time-Dependent MannerAngelo Iacobino, Giovanni Piccaro, Manuela Pardini, et al.
International Journal of Mycobacteriology|August 5, 2017
Fighting tuberculosis by drugs targeting nonreplicating <i>Mycobacterium tuberculosis</i> bacilliAngelo Iacobino, Giovanni Piccaro, Federico Giannoni, et al.
Antimicrobial Agents and Chemotherapy|March 31, 2010
Activity of drug combinations against dormant Mycobacterium tuberculosisPerla Filippini, Elisabetta Iona, Giovanni Piccaro, et al.
Annali Dell'Istituto Superiore Di Sanita|December 19, 2019
Use of probiotics in medical devices applied to some common pathologiesMaria Verrucci, Angelo Iacobino, Lanfranco Fattorini, et al.
Pageof 3